# Dietary Iron Supplementation Protects Against Growth Restriction and Metabolic Dysfunction‐Associated Steatotic Liver Disease in Perinatal Cadmium‐Exposed Mice

**Authors:** Rebecca Lichtler, Hannah Klossner, Nikia Smith, Cathrine Hoyo, Michael Cowley

PMC · DOI: 10.1096/fba.2025-00045 · FASEB BioAdvances · 2025-06-17

## TL;DR

Adding iron to the diet of pregnant mice exposed to cadmium prevents iron deficiency and liver disease in their offspring.

## Contribution

This study shows that dietary iron supplementation can counteract the harmful effects of maternal cadmium exposure on offspring.

## Key findings

- Maternal cadmium exposure causes iron deficiency and liver disease in offspring.
- Iron supplementation prevents growth restriction and liver disease in offspring.
- Supplemental iron is absorbed despite cadmium exposure.

## Abstract

Iron (Fe)‐deficiency (ID) and Fe‐deficiency anemia (IDA) are highly prevalent conditions and are of particular concern to maternal–child health. ID and IDA are typically linked to nutritional deficiencies, but maternal exposure to heavy metals including cadmium (Cd) also leads to offspring with low levels of circulating Fe. Another comorbidity of ID and IDA is metabolic dysfunction‐associated steatotic liver disease (MASLD), a liver condition characterized by lipid accumulation and fibrosis. We have previously shown that maternal Cd exposure also leads to the development of MASLD in offspring. We hypothesized that providing Fe fortification would prevent Cd‐induced ID, which would in turn rescue offspring from growth restriction and MASLD. To test this, virgin dams were exposed to 30 ppm of cadmium chloride (CdCl2) in their drinking water during the preconception, gestation, and lactation periods. Fe fortification was supplied in the form of dietary ferric citrate, which amounted to two (2×) or five times (5×) the normal dietary Fe in standard chow. Our study provides evidence that perinatal Cd exposure does not prevent absorption of supplemental Fe, and that the chosen Fe supplementation dosages are sufficient to prevent Cd‐induced growth restriction, ID, IDA, and MASLD in offspring at postnatal day 21 (PND21). Our findings suggest that Fe supplementation may be a viable therapy to prevent these developmental effects of maternal Cd exposure.

Developmental cadmium (Cd) exposure causes iron deficiency (ID) and impacts growth and metabolism. To test whether iron (Fe) supplementation prevents Cd‐induced effects, female mice were given water and normal chow, or water with Cd in combination with normal chow or chow fortified with 2× or 5× Fe. Offspring of mice exposed to Cd alone developed ID, ID anemia (IDA), restricted growth, and signatures of metabolic dysfunction‐associated steatotic liver disease MASLD. These outcomes were largely rescued by supplemental dietary Fe.

## Linked entities

- **Chemicals:** iron (PubChem CID 23925), ferric citrate (PubChem CID 61300), cadmium (PubChem CID 23973), cadmium chloride (PubChem CID 24947)
- **Diseases:** iron-deficiency anemia (MONDO:0001356), metabolic dysfunction-associated steatotic liver disease (MONDO:0013209)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Col5a1 (collagen, type V, alpha 1) [NCBI Gene 12831], Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, Ctsd (cathepsin D) [NCBI Gene 13033] {aka CD, CatD}, Hamp2 (hepcidin antimicrobial peptide 2) [NCBI Gene 66438] {aka 1810073K19Rik, HEPC2}, Ccr2 (C-C motif chemokine receptor 2) [NCBI Gene 12772] {aka Cc-ckr-2, Ccr2a, Ccr2b, Ckr2, Ckr2a, Ckr2b}, Il6ra (interleukin 6 receptor, alpha) [NCBI Gene 16194] {aka CD126, IL-6R, IL-6R-alpha, IL-6RA, Il6r}, Col1a1 (collagen, type I, alpha 1) [NCBI Gene 12842] {aka Col1a-1, Cola-1, Cola1, Mov-13, Mov13}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Bmp6 (bone morphogenetic protein 6) [NCBI Gene 12161] {aka D13Wsu115e, Vgr1}, Slc40a1 (solute carrier family 40 (iron-regulated transporter), member 1) [NCBI Gene 53945] {aka Dusg, Fpn1, IREG1, MTP, MTP1, Ol5}, Hamp (hepcidin antimicrobial peptide) [NCBI Gene 84506] {aka Hamp1, Hepc, Hepc1}, Plagl1 (pleiomorphic adenoma gene-like 1) [NCBI Gene 22634] {aka 2610311E24Rik, Lot1, Zac1}, Col5a2 (collagen, type V, alpha 2) [NCBI Gene 12832] {aka 1110014L14Rik}, Col6a1 (collagen, type VI, alpha 1) [NCBI Gene 12833] {aka Col6a-1}, Vim (vimentin) [NCBI Gene 22352]
- **Diseases:** motor dysfunction (MESH:D000068079), LBW (MESH:D001724), Organ mass (MESH:C536030), ID anemia (MESH:D018798), Hepatic fibrosis (MESH:D008103), MASLD (MESH:D008107), hepatic Fe toxicity (MESH:D056486), Fe-deficiency anemia (MESH:D000740), lipid (MESH:D011017), NAFLD (MESH:D065626), cardiac hypertrophy (MESH:D006332), heart muscle (MESH:D006331), hemoglobin deficit (MESH:D009461), Hepatic steatosis (MESH:D005234), muscle atrophy (MESH:D009133), ID (MESH:C537985), fibrosis (MESH:D005355), hepatic Fe overload (MESH:D019190), FGR (MESH:D005317), Chronic liver inflammation (MESH:D007249), liver atrophy (MESH:D017093), infection (MESH:D007239), Metabolic Dysfunction (MESH:D008659), attention-deficit/hyperactivity disorder (MESH:D001289), ID (MESH:D000090463), obesity (MESH:D009765), nutritional deficiencies (MESH:D044342), poisoning (MESH:D011041), Fe deficiency (MESH:D007153), stunted growth (MESH:D006130), Hair loss (MESH:D000505), prematurity (MESH:C536271), alcohol toxicity (MESH:D019973), hypertrophic (MESH:D002312), cognitive delays (MESH:D003072), toxicity (MESH:D064420), mitochondrial dysfunction (MESH:D028361)
- **Chemicals:** lipid (MESH:D008055), Triglycerides (MESH:D014280), H&amp;E (MESH:D006371), ORO (MESH:C011049), alcohol (MESH:D000438), eosin (MESH:D004801), PFA (MESH:C003043), CdCl2 (MESH:D019256), lead (MESH:D007854), water (MESH:D014867), fatty acid (MESH:D005227), Mn (MESH:D008345), yttrium (MESH:D015019), nitric acid (MESH:D017942), heavy metal (MESH:D019216), indium (MESH:D007204), Cu (MESH:D003300), ethanol (MESH:D000431), potassium hydroxide (MESH:C029943), SYBR Green (MESH:C098022), ferric citrate (MESH:C025314), hematoxylin (MESH:D006416), Hydroxyproline (MESH:D006909), germanium (MESH:D005857), paraffin (MESH:D010232), Fe (MESH:D007501), praseodymium (MESH:D011221), EDTA (MESH:D004492), oxygen (MESH:D010100), PlasmaPure Plus nitric acid (-), Cadmium (MESH:D002104), HCl (MESH:D006851)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** M170A, D10012G

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12312208/full.md

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12312208/full.md

## References

74 references — full list in the complete paper: https://tomesphere.com/paper/PMC12312208/full.md

---
Source: https://tomesphere.com/paper/PMC12312208